Phase II study of 1,2,4-triglycidyl urasol (TGU) in advanced soft tissue sarcoma. A trial of the EORTC Soft Tissue and Bone Sarcoma Cooperative Group.

Authors :: Rouëssé JG
van Oosterom AT
Capellaere P
Kerbrat P
van Coninge CJ
Thomas D
Benshahar D
Source :: European journal of cancer & clinical oncology [Eur J Cancer Clin Oncol] 1987 Sep; Vol. 23 (9), pp. 1413-4.
Publication Year :: 1987

Subjects :: Adult
Aged
Drug Evaluation
Female
Humans
Leukopenia chemically induced
Male
Middle Aged
Thrombocytopenia chemically induced
Triazoles adverse effects
Antineoplastic Agents therapeutic use
Sarcoma drug therapy
Soft Tissue Neoplasms drug therapy
Triazoles therapeutic use

Full Text Access

Tools